Element Capital Management’s Charles River Laboratories CRL Stock Holding History

Element Capital Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,956	Closed	-$579K	–	61
2023 Q3	$579K	Sell	2,956 -4,117	-58%	-$845K	0.05%	211
2023 Q2	$1.49M	Buy	7,073 +357	+5%	+$71K	0.1%	190
2023 Q1	$1.36M	Buy	+6,716	New	+$1.52M	0.1%	143
2019 Q1	–	Sell	-2,567	Closed	-$291K	–	846
2018 Q4	$291K	Sell	2,567 -262	-9%	-$32.8K	0.01%	457
2018 Q3	$381K	Buy	+2,829	New	+$349K	0.01%	501
2015 Q3	–	Sell	-900	Closed	-$63.3K	–	155
2015 Q2	$63.3K	Buy	+900	New	+$66.6K	0.02%	230

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Element Capital Management's CRL Position: Q4 2023 in Review

Element Capital Management sold out of Charles River Laboratories (CRL) in Q4 2023, closing a stake of 2,956 shares — an estimated $579K sold.

Element Capital Management first reported a position in CRL in Q2 2015 and held it in 6 quarters. The position peaked at $1.49M in Q2 2023. 634 funds tracked by Wall St. Rank hold CRL as of Q4 2023.

Element Capital Management reported no remaining Charles River Laboratories position as of Q4 2023 after selling out during the quarter.
Element Capital Management sold 2,956 Charles River Laboratories shares in Q4 2023, an estimated $579K.
Element Capital Management first reported a position in Charles River Laboratories in Q2 2015 and held it in 6 quarters.
Element Capital Management's Charles River Laboratories position peaked at $1.49M in Q2 2023.
634 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2023.

Based on Element Capital Management's 13F filing for Q4 2023, filed 9 Feb 2024.